| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/05/2006 | US20060003403 Carotenoid ketolase genes with improved ketocarotenoid yield |
| 01/05/2006 | US20060003393 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 01/05/2006 | US20060003387 Cell display libraries |
| 01/05/2006 | US20060003379 Smad6 and uses thereof |
| 01/05/2006 | US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 01/05/2006 | US20060003377 Therapeutic and diagnostic proteins comprising a SOCS box |
| 01/05/2006 | US20060003375 Novel polypeptide - human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same |
| 01/05/2006 | US20060003374 Coupling amine terminated PNA oligomer or an amine terminated cleavable linker on a solid phase synthesis resin with a benzothiole-2-sulfonyl derivative, capping unprotected amine with actetic anhydride, cleaving over reacted acetyl group, deprotecting benzothiole-2-sulfonyl group, repeating above steps |
| 01/05/2006 | US20060003358 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/05/2006 | US20060003357 Solid phase technique for selectively isolating nucleic acids |
| 01/05/2006 | US20060003355 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/05/2006 | US20060003353 Incubate with primer, polymerase and nucleotide triphosphates, amplify sequences, digest, ligate and recover; cloning |
| 01/05/2006 | US20060003347 Single-molecule in vitro evolution |
| 01/05/2006 | US20060003341 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 01/05/2006 | US20060003334 Protein (poly)peptides libraries |
| 01/05/2006 | US20060003330 Streptococcus pneumoniae pbp2x mini-protein and uses thereof |
| 01/05/2006 | US20060003325 Method of detecting base mutation |
| 01/05/2006 | US20060003324 Method for producing gene libraries |
| 01/05/2006 | US20060003322 a nucleotide sequence of a first half of said RNA precursor is a partial inversed-reversed sequence of a nucleotide sequence of a second half |
| 01/05/2006 | US20060003316 Immunogenic compositions derived from poxviruses and methods of using same |
| 01/05/2006 | US20060003315 Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes |
| 01/05/2006 | US20060003314 Methods for peptide and protein display in nucleic acid arrays |
| 01/05/2006 | US20060003311 In vitro screening of cellular events using 3d cell culture systems |
| 01/05/2006 | US20060003310 Device for performing cell assays |
| 01/05/2006 | US20060003308 Sterilized cell cuvette containing frozen, transformable cells; gene expression analysis; heterologous protein synthesis |
| 01/05/2006 | US20060003145 Ultra-smooth microfabricated pores on a planar substrate for integrated patch-clamping |
| 01/05/2006 | US20060002961 Immunogens; Streptococcus pneumoniae polysaccharide-protein conjugate/antigen, and adjuvant which induces (cytotoxic T) lymphocytes |
| 01/05/2006 | US20060002958 Attenuation of metapneumovirus |
| 01/05/2006 | US20060002952 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 01/05/2006 | US20060002945 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders |
| 01/05/2006 | US20060002939 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 01/05/2006 | US20060002935 Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor |
| 01/05/2006 | US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators) |
| 01/05/2006 | US20060002923 Recombinant anti-osteopontin antibody and use thereof |
| 01/05/2006 | US20060002919 15625 receptor, a novel G-protein coupled receptor |
| 01/05/2006 | US20060002905 Mutant forms of EtxB and CtxB and their use as carriers |
| 01/05/2006 | US20060002897 Plasmid for tissue targeted treatment of tumors; antitumor agents |
| 01/05/2006 | US20060002896 Method of generating recombinant MVA |
| 01/05/2006 | US20060002895 Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 01/05/2006 | US20060002894 Method for introducing a biological molecule using a viral envelope and composition and system therefor |
| 01/05/2006 | US20060002893 Targeted adenovirus vectors for delivery of heterologous genes |
| 01/05/2006 | US20060000758 Reacting an inorganic support with acetoxy alkyltriethoxysilane and a linker; reacting the linker with a catalyst; reducing non-specific binding to an inorganic support; high activity, selectivity, easily recovered from reaction solutions for subsequent reuse |
| 01/05/2006 | DE3891417C5 Verfahren zur Veränderung eines L-Threonin produzierenden Mikroorganismus und Verwendung eines so erhaltenen Mikroorganismus zur Herstellung von L-Threonin Method for modifying an L-threonine-producing microorganism and using a thus obtained microorganism for producing L-threonine |
| 01/05/2006 | DE10226675B4 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances |
| 01/05/2006 | DE10226674B4 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances |
| 01/05/2006 | DE102004029763A1 Pflanzen, die Amylopektin-Stärke mit neuen Eigenschaften herstellen Plants which produce amylopectin starch with new properties |
| 01/05/2006 | DE102004029112A1 Alkoholdehydrogenase zur stereoselektiven Gewinnung von Hydroxyverbindungen Alcohol for the stereoselective production of hydroxy |
| 01/05/2006 | DE102004027516A1 New isolated proteins and peptides, useful for synthesis of efomycin antibiotics, also nucleic acid sequences encoding them and genetically modified host cells |
| 01/05/2006 | DE102004026135A1 An MHC-Moleküle bindende Tumor-assoziierte Peptide Binding to MHC molecules tumor-associated peptides |
| 01/05/2006 | DE102004025881A1 Oligoribonukleotide zur Beeinflussung des Haarwachstums Oligoribonucleotides for influencing of hair growth |
| 01/05/2006 | CA2589563A1 Method of screening compound directly activating glycogen synthase |
| 01/05/2006 | CA2572330A1 Gdf3 propeptides and related methods |
| 01/05/2006 | CA2572155A1 Cell network analysis system |
| 01/05/2006 | CA2572015A1 Fc-interferon-beta fusion proteins |
| 01/05/2006 | CA2571852A1 Inhibition of infiltration, and cell killing agent |
| 01/05/2006 | CA2571849A1 Anticancer agent containing dendritic cell having rna virus transferred thereinto |
| 01/05/2006 | CA2571844A1 Anticancer agent containing minus-strand rna virus |
| 01/05/2006 | CA2571781A1 Chimeric proteins and uses thereof |
| 01/05/2006 | CA2570778A1 Prrsv subunit vaccines |
| 01/05/2006 | CA2568807A1 Method for increasing pathogen-resistance in transgenic plants by expression of peroxidase |
| 01/05/2006 | CA2568661A1 Human monoclonal antibodies to fc gamma receptor i (cd64) |
| 01/05/2006 | CA2568150A1 Medical systems and methods for delivering compositions to cells |
| 01/05/2006 | CA2560631A1 Improved inhibitor nucleic acids |
| 01/05/2006 | CA2558760A1 Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera |
| 01/05/2006 | CA2470922A1 Cassette-based strategy for engineering multiple domain fusion proteins |
| 01/04/2006 | EP1612281A2 Methods for assessing patients with acute myeloid leukemia |
| 01/04/2006 | EP1612280A2 Diagnosis and treatment of Williams syndrome |
| 01/04/2006 | EP1612277A1 Method for noncovalently immobilizing a biomolecule on a solid substrate and microarray produced according to the method |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612271A2 Multiply-substituted protease variants with altered net charge for use in detergents |
| 01/04/2006 | EP1612270A2 Rétroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/04/2006 | EP1612269A1 Use of replication-deficient adenoviral vector to boost CD8+ T cell immune response to antigen |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612265A2 Bioengineered tissue constructs and methods for producing and using them |
| 01/04/2006 | EP1612263A1 PTH receptor and screening assay utilizing the same |
| 01/04/2006 | EP1612223A2 Polypeptides with FC binding ability |
| 01/04/2006 | EP1612222A2 Olfactory and pheromones G-protein coupled receptors |
| 01/04/2006 | EP1612221A2 Receptor-based interaction trap |
| 01/04/2006 | EP1612219A1 Allergen from house-dust mites |
| 01/04/2006 | EP1612218A1 Surface protein of Neisseria bacteria |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611785A1 Cloning of transgenic ungulate animals comprising artificial chromosomes |
| 01/04/2006 | EP1611249A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 01/04/2006 | EP1611248A1 Diagnostic method for glaucoma |
| 01/04/2006 | EP1611245A1 Process for the production of l-amino acids using strains of the enterobacteriaceae family which contain an enhance yfidd orf and/or pfld gene |
| 01/04/2006 | EP1611243A2 4-ketocarotenoids in flower petals |
| 01/04/2006 | EP1611242A1 RICE CONFERRING RESISTANCE TO ENVIRONMENTAL STRESS BY TARGETING MnSOD TO THE CHLOROPLAST |
| 01/04/2006 | EP1611241A2 Method for producing l-amino acid using bacteria having enhanced expression of the gene pcka |
| 01/04/2006 | EP1611240A2 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 01/04/2006 | EP1611239A1 Cyclic amp response element activator proteins and uses related thereto |
| 01/04/2006 | EP1611238A2 Glutamate transport modulatory compounds and methods |
| 01/04/2006 | EP1611237A1 Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby |
| 01/04/2006 | EP1611231A2 Rna interference compositions and methods |
| 01/04/2006 | EP1611152A2 Adp-ribosylating toxin from listeria monocytogenes |
| 01/04/2006 | EP1610824A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 01/04/2006 | EP1610816A2 Mva virus expressing modified hiv envelope, gag, and pol genes |
| 01/04/2006 | EP1610809A2 Vault and vault-like carrier molecules |
| 01/04/2006 | EP1610755A2 Phosphodiesterase 2a and methods of use |
| 01/04/2006 | EP1610612A2 Endosomolytic polymers |